Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis.

He HR, Chen SY, You HS, Hu SS, Sun JY, Dong YL, Lu J.

Pharmacogenomics J. 2014 Oct;14(5):432-8. doi: 10.1038/tpj.2014.10. Epub 2014 Mar 18.

PMID:
24637499
2.

Methylenetetrahydrofolate reductase gene polymorphisms: association with risk for pediatric acute lymphoblastic leukemia in north Indians.

Sood S, Das R, Trehan A, Ahluwalia J, Sachdeva MU, Varma N, Bansal D, Marwaha RK.

Leuk Lymphoma. 2010 May;51(5):928-32. doi: 10.3109/10428191003719023.

PMID:
20367562
3.

A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.

Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, Garcia-Orad A.

Pharmacogenomics J. 2013 Dec;13(6):498-506. doi: 10.1038/tpj.2012.44. Epub 2012 Oct 23. Review.

PMID:
23089671
4.

Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.

Oh D, Kim NK, Jang MJ, Kim HC, Lee JH, Lee JA, Ahn MJ, Kim CS, Kim HS, Park S, Chio HS, Min YH; HOGS Investigators.

Anticancer Res. 2007 Sep-Oct;27(5A):3419-24.

5.

C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.

Eissa DS, Ahmed TM.

Blood Coagul Fibrinolysis. 2013 Mar;24(2):181-8. doi: 10.1097/MBC.0b013e32835b249d.

PMID:
23183238
7.

Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.

Tantawy AA, El-Bostany EA, Adly AA, Abou El Asrar M, El-Ghouroury EA, Abdulghaffar EE.

Blood Coagul Fibrinolysis. 2010 Jan;21(1):28-34. doi: 10.1097/MBC.0b013e32833135e9. Erratum in: Blood Coagul Fibrinolysis. 2010 Mar;21(2):200.

PMID:
19923983
8.

A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children.

Yan J, Yin M, Dreyer ZE, Scheurer ME, Kamdar K, Wei Q, Okcu MF.

Pediatr Blood Cancer. 2012 Apr;58(4):513-8. doi: 10.1002/pbc.23137. Epub 2011 Apr 14. Review.

PMID:
21495160
9.
10.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.

Mosaad YM, Abousamra NK, Elashery R, Fawzy IM, Eldein OA, Sherief DM, El Azab HM.

Leuk Lymphoma. 2015;56(9):2699-705. doi: 10.3109/10428194.2015.1004170. Epub 2015 Feb 24.

PMID:
25629981
11.

Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Kantar M, Kosova B, Cetingul N, Gumus S, Toroslu E, Zafer N, Topcuoglu N, Aksoylar S, Cinar M, Tetik A, Eroglu Z.

Leuk Lymphoma. 2009 Jun;50(6):912-7. doi: 10.1080/10428190902893819.

PMID:
19391036
12.

Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.

Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T.

Cancer Res. 2005 Mar 15;65(6):2482-7.

13.

5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.

Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1956-63. Review.

14.

Methylenetetrahydrofolate reductase polymorphisms and susceptibility to acute lymphoblastic leukemia in a Chinese population: a meta-analysis.

Xiao Y, Deng TR, Su CL, Shang Z.

Oncol Res Treat. 2014;37(10):576-82. doi: 10.1159/000368104. Epub 2014 Sep 16. Review.

PMID:
25342508
15.

Methylenetetrahydrofolate reductase gene polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis based on 28 case-control studies.

Tong N, Sheng X, Wang M, Fang Y, Shi D, Zhang Z, Zhang Z.

Leuk Lymphoma. 2011 Oct;52(10):1949-60. doi: 10.3109/10428194.2011.589545. Epub 2011 Jun 24.

PMID:
21702646
16.

Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis.

Yang L, Hu X, Xu L.

Tumour Biol. 2012 Oct;33(5):1445-54. doi: 10.1007/s13277-012-0395-2. Epub 2012 Apr 20.

PMID:
22528943
17.

The association of methylenetetrahydrofolate reductase genotypes with the risk of childhood leukemia in Taiwan.

Pei JS, Hsu CM, Tsai CW, Chang WS, Ji HX, Hsiao CL, Miao CE, Hsu YN, Bau DT.

PLoS One. 2015 Mar 20;10(3):e0119776. doi: 10.1371/journal.pone.0119776. eCollection 2015.

18.

Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia.

Kim NK, Chong SY, Jang MJ, Hong SH, Kim HS, Cho EK, Lee JA, Ahn MJ, Kim CS, Oh D.

Anticancer Res. 2006 Jul-Aug;26(4B):2879-81.

19.

Methylenetetrahydrofolate reductase polymorphism C677T is a protective factor for pediatric acute lymphoblastic leukemia in the Chinese population: a meta-analysis.

Wang H, Meng L, Zhao L, Wang J, Liu X, Mi W.

Genet Test Mol Biomarkers. 2012 Dec;16(12):1401-7. doi: 10.1089/gtmb.2012.0184. Epub 2012 Oct 12.

PMID:
23061880
20.

Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis.

Wu YL, Hu CY, Lu SS, Gong FF, Feng F, Qian ZZ, Ding XX, Yang HY, Sun YH.

Metabolism. 2014 Dec;63(12):1503-11. Review.

PMID:
25458833

Supplemental Content

Support Center